<DOC>
	<DOC>NCT02208791</DOC>
	<brief_summary>The purpose of this study is to determine the effects of sirolimus in the phenotype of peripheral blood T and B lymphocytes regarding their na√Øve, memory, effector end regulatory phenotype and in the development of anti-HLA antibodies among kidney transplant recipients with high immunological risk for graft rejection.</brief_summary>
	<brief_title>Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant</brief_title>
	<detailed_description />
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Men and women, ages 18 to 60 years inclusive Percentage of Panel Reactive Antibodies at transplantation &gt; 20% Estimated glomerular filtration rate using MDRD formula at inclusion &gt;29ml/min Subjects with a history of cancer Subjects with a previous non kidney transplantation Subjects receiving any immunosuppression different of tacrolimus/prednisone/mycophenolate Subjects with a urinary protein/creatinine ratio greater than 0.3 Subjects with active HBV, HCV and HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Graft Rejection</keyword>
	<keyword>Immunossupression</keyword>
</DOC>